Lv61
2086 积分 2023-02-27 加入
Unlocking T-cell receptor–epitope insights with structural analysis
2天前
已完结
Unlocking comprehensive molecular design across all scenarios with large language model and unordered chemical language
11天前
已完结
T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells
20天前
已完结
AI-driven cellular immunotherapy: transforming CAR-T engineering and translation
21天前
已完结
Computational modeling and optimization of scFv-based receptors to support CAR-T design targeting CD19 for enhanced binding robustness and reduced off-target propensity
25天前
已完结
Computational design of CAR-scFv linker variants for enhanced CD20 binding against B-cell malignancies
25天前
已完结
Targeting overexpressed antigens in glioblastoma via CAR T cells with computationally designed high-affinity protein binders
27天前
已完结
Abstract 5980: AUBE00: A novel cyclic peptide pan-KRAS inhibitor targeting KRAS-activated cancers including KRAS-mutant cancers and wild-type colorectal cancer
1个月前
已关闭
Abstract 5138: Chemical optimization of an orally bioavailable macrocyclic peptide KRAS inhibitors that achieve KRAS selectivity by recognizing a single amino acid difference
1个月前
已完结
Hemoglobin-based Oxygen Carriers: Current State-of-the-art and Novel Molecules
1个月前
已完结
皖公网安备34019202002308
